FDA Inspection
AstraZeneca Pharmaceuticals, LPAstraZeneca Pharmaceuticals, LP – FDA Inspection, Jun 26, 2026
Record Details
This FDA Inspection record concerns AstraZeneca Pharmaceuticals, LP, with an inspection on June 26, 2026, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · 5b9f5d62-badb-435a-b322-32630163e2b4
Inspection Facts
- Inspection number
- 1327360
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AstraZeneca Pharmaceuticals, LP
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 26, 2024 | Not classified | Philadelphia District Office | |
| July 19, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2017 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| August 27, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 28, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca Pharmaceuticals, LP
- FDA Inspection 1236034 - 2024-04-26
- FDA Inspection 1211584 - 2023-07-19
- FDA Inspection 1022686 - 2017-08-24
- FDA Inspection 895233 - 2014-08-27
- FDA Inspection 788561 - 2011-11-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.